Add Yahoo as a preferred source to see more of our stories on Google. In people with type 1 diabetes, insulin must be taken every day as their pancreas cannot produce the hormone itself. However a new ...

(Reuters) - Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for maintaining blood sugar levels in patients with type 1 or type 2 diabetes ...

Weekly insulin injections can control type 1 and type 2 diabetes just as well as daily shots, according to two new studies. Two phase 3 trials presented Tuesday at the European Association for the ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...

Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.

One trial found that using injectable insulin icodec once a week was as effective as using a standard injectable form of insulin once a day. The other trial found that it seems to be safe and ...

Please provide your email address to receive an email when new articles are posted on . Insulin efsitora alfa conferred noninferior HbA1c reductions vs. insulin degludec in two phase 3 trials. Level ...

The approval of Eli Lilly’s Mounjaro (tirzepatide) KwikPen by India’s Central Drugs Standard Control Organisation (CDSCO) marks a significant development in diabetes and obesity management, not only ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Insulin efsitora was noninferior to once-daily insulins ...

Sept 11 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present the latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free ...